OBJECTIVES: In 2015, the Selecting Therapeutic Targets in Inflammatory Bowel Disease
(STRIDE) program proposed shifting the therapeutic focus on ulcerative colitis (UC) toward …

Therapeutic advances in the management of IBD have led to a paradigm shift in the
assessment of IBD disease activity. Beyond clinical remission, objective assessment of …

Background The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)
initiative of the International Organization for the Study of Inflammatory Bowel Diseases …

Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the
preferred approach to the management of adults with UC and represent the official practice …

Automatic detection of diseases by use of computers is an important, but still unexplored
field of research. Such innovations may improve medical practice and refine health care …

Background Endoscopic mucosal healing is an established treatment target for UC, yet the
value of achieving histological remission remains unclear. Aims To evaluate histological …

Abstract Background and Aims Few population-based cohort studies have assessed the
disease course of ulcerative colitis [UC] in the era of biological therapy and widespread use …

Background and aims: Mucosal healing in ulcerative colitis (UC) has become a common
endpoint in most clinical trials and a relevant therapeutic goal in clinical practice. Despite …

Abstract Background and Aims Vitamin D may be immunomodulatory and alter faecal
microbiota, but results from clinical studies in humans to date have been inconclusive. This …

Background and aim: Vitamin D deficiency is common in inflammatory bowel disease (IBD).
The aims of the present study were to determine the prevalence of vitamin D deficiency and …